MARATHON CAPITAL MANAGEMENT

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1213206 Hunt Valley, MD

Position in RXRX

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$79,620

-$384,855 QoQ

Shares Held

21,695

-85.7% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#205

of 343 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MARATHON CAPITAL MANAGEMENT holds $5,159,453 across 4 Biotechnology names. RXRX ranks #4 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADMA	Adma Biologics, Inc.	532,353	$4,455,794
2	RPRX	Royalty Pharma plc	9,364	$525,039
3	DYAI	Dyadic International Inc	110,000	$99,000
4	RXRX	Recursion Pharmaceuticals, Inc. This page	21,695	$79,620

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$79,620	21,695	-85.7%	Shares	Sole	2026-07-22
2026-03-31	$464,475	151,295	+4.6%	Shares	Sole	2026-05-14
2025-12-31	$591,393	144,595	+3.3%	Shares	Sole	2026-01-29
2025-09-30	$683,175	139,995	-1.3%	Shares	Sole	2025-11-14
2025-06-30	$717,988	141,895	-5.3%	Shares	Sole	2025-08-14
2025-03-31	$792,680	149,845	+2.4%	Shares	Sole	2025-05-15
2024-12-31	$989,630	146,395	-19.5%	Shares	Sole	2025-02-14
2024-09-30	$1,198,358	181,845	+3.8%	Shares	Sole	2024-11-14
2024-06-30	$1,314,150	175,220	+1.6%	Shares	Sole	2024-08-14
2024-03-31	$1,720,273	172,545	+4.6%	Shares	Sole	2024-05-15
2023-12-31	$1,625,716	164,880	-3.4%	Shares	Sole	2024-02-14
2023-09-30	$1,305,204	170,615	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.